These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 31310608)

  • 1. D-dimer levels during and after anticoagulation withdrawal in patients with venous thromboembolism treated with non-vitamin K anticoagulants.
    Legnani C; Martinelli I; Palareti G; Ciavarella A; Poli D; Ageno W; Testa S; Mastroiacovo D; Ciammaichella M; Bucherini E; Mumoli N; Cosmi B
    PLoS One; 2019; 14(7):e0219751. PubMed ID: 31310608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism.
    Douketis J; Tosetto A; Marcucci M; Baglin T; Cushman M; Eichinger S; Palareti G; Poli D; Tait RC; Iorio A
    Ann Intern Med; 2010 Oct; 153(8):523-31. PubMed ID: 20956709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review: D-dimer to predict recurrent disease after stopping anticoagulant therapy for unprovoked venous thromboembolism.
    Verhovsek M; Douketis JD; Yi Q; Shrivastava S; Tait RC; Baglin T; Poli D; Lim W
    Ann Intern Med; 2008 Oct; 149(7):481-90, W94. PubMed ID: 18838728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term risk of recurrence in patients with a first unprovoked venous thromboembolism managed according to d-dimer results; A cohort study.
    Kearon C; Parpia S; Spencer FA; Schulman S; Stevens SM; Shah V; Bauer KA; Douketis JD; Lentz SR; Kessler CM; Connors JM; Ginsberg JS; Spadafora L; Julian JA
    J Thromb Haemost; 2019 Jul; 17(7):1144-1152. PubMed ID: 31033194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D-dimer and risk of venous thromboembolism recurrence: Comparison of two studies with similar designs but different laboratory and clinical results.
    Palareti G; Legnani C; Tosetto A; Poli D; Testa S; Ageno W; Pengo V; Cosmi B; Prandoni P
    Thromb Res; 2024 Jun; 238():52-59. PubMed ID: 38669963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D-dimer testing, with gender-specific cutoff levels, is of value to assess the individual risk of venous thromboembolic recurrence in non-elderly patients of both genders: a post hoc analysis of the DULCIS study.
    Palareti G; Legnani C; Antonucci E; Cosmi B; Poli D; Testa S; Tosetto A; Ageno W; Falanga A; Ferrini PM; Pengo V; Prandoni P;
    Intern Emerg Med; 2020 Apr; 15(3):453-462. PubMed ID: 31691119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How D-dimer assay can be useful in deciding the duration of anticoagulation after venous thromboembolism: a review.
    Palareti G
    Expert Rev Hematol; 2015 Feb; 8(1):79-88. PubMed ID: 25348806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D-Dimer Levels and Vitamin K Antagonist Therapy in Deep Vein Thrombosis of the Legs.
    Park JK; Koo do H; Yoon DH; Lee JN
    Ann Vasc Surg; 2016 Jul; 34():119-34. PubMed ID: 27177705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different cut-off values of quantitative D-dimer methods to predict the risk of venous thromboembolism recurrence: a post-hoc analysis of the PROLONG study.
    Legnani C; Palareti G; Cosmi B; Cini M; Tosetto A; Tripodi A;
    Haematologica; 2008 Jun; 93(6):900-7. PubMed ID: 18443269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The negative predictive value of D-dimer on the risk of recurrent venous thromboembolism in patients with multiple previous events: a prospective cohort study (the PROLONG PLUS study).
    Ageno W; Cosmi B; Ghirarduzzi A; Santoro R; Bucherini E; Poli D; Prisco D; Alatri A; Pengo V; Galli L; Dentali F; Palareti G
    Am J Hematol; 2012 Jul; 87(7):713-5. PubMed ID: 22488507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of anticoagulation selection for acute venous thromboembolism.
    Badreldin H; Nichols H; Rimsans J; Carter D
    J Thromb Thrombolysis; 2017 Jan; 43(1):74-78. PubMed ID: 27592341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH).
    Tosetto A; Iorio A; Marcucci M; Baglin T; Cushman M; Eichinger S; Palareti G; Poli D; Tait RC; Douketis J
    J Thromb Haemost; 2012 Jun; 10(6):1019-25. PubMed ID: 22489957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. All-Cause Mortality Risk with Direct Oral Anticoagulants and Warfarin in the Primary Treatment of Venous Thromboembolism.
    Roetker NS; Lutsey PL; Zakai NA; Alonso A; Adam TJ; MacLehose RF
    Thromb Haemost; 2018 Sep; 118(9):1637-1645. PubMed ID: 30103250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort study.
    Kearon C; Spencer FA; O'Keeffe D; Parpia S; Schulman S; Baglin T; Stevens SM; Kaatz S; Bauer KA; Douketis JD; Lentz SR; Kessler CM; Moll S; Connors JM; Ginsberg JS; Spadafora L; Julian JA;
    Ann Intern Med; 2015 Jan; 162(1):27-34. PubMed ID: 25560712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety ad efficacy of direct oral anticoagulants for extended treatment of venous thromboembolism.
    Imberti D; Pomero F; Benedetti R; Fenoglio L
    Intern Emerg Med; 2016 Oct; 11(7):895-900. PubMed ID: 27550399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D-dimer testing to determine the duration of anticoagulation therapy.
    Palareti G; Cosmi B; Legnani C; Tosetto A; Brusi C; Iorio A; Pengo V; Ghirarduzzi A; Pattacini C; Testa S; Lensing AW; Tripodi A;
    N Engl J Med; 2006 Oct; 355(17):1780-9. PubMed ID: 17065639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of D-Dimer Testing in Predicting Recurrence in Elderly Patients with Unprovoked Venous Thromboembolism.
    Tritschler T; Limacher A; Méan M; Rodondi N; Aujesky D
    Am J Med; 2017 Oct; 130(10):1221-1224. PubMed ID: 28522384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia.
    Palareti G; Legnani C; Cosmi B; Valdré L; Lunghi B; Bernardi F; Coccheri S
    Circulation; 2003 Jul; 108(3):313-8. PubMed ID: 12847064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of direct oral factor Xa inhibitors compared with warfarin in patients with morbid obesity: a single-centre, retrospective analysis of chart data.
    Kushnir M; Choi Y; Eisenberg R; Rao D; Tolu S; Gao J; Mowrey W; Billett HH
    Lancet Haematol; 2019 Jul; 6(7):e359-e365. PubMed ID: 31133411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should D-dimer testing be used to predict the risk of recurrence after discontinuation of anticoagulant therapy for a first unprovoked episode of venous thromboembolism?
    Wu C; Bates SM
    Pol Arch Med Wewn; 2009 Apr; 119(4):225-30. PubMed ID: 19413181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.